S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
Log in
NASDAQ:MBRX

Moleculin Biotech Short Interest Ratio and Short Volume

$4.29
-0.05 (-1.15 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.21
Now: $4.29
$4.45
50-Day Range
$0.83
MA: $5.10
$6.42
52-Week Range
$1.94
Now: $4.29
$11.82
Volume559,059 shs
Average Volume3.41 million shs
Market Capitalization$112.74 million
P/E RatioN/A
Dividend YieldN/A
Beta2.11

Short Interest

Moleculin Biotech (NASDAQ:MBRX) Short Interest Data

Current Short Volume416,500 shares
Previous Short Volume2,760,000 shares
Change Vs. Previous Month:-84.91%
Dollar Volume Sold Short$1.76 million
Short Interest Ratio / Days to Cover0.2
Last Record DateFebruary, 12 2021
Outstanding Shares45,190,000 shares
Float Size23,600,000 shares
Short Percent of Float1.76%
Today's Trading Volume559,059 shares
Average Trading Volume3,413,008 shares
Today's Volume Vs. Average-83.62%

Short Interest Over Time


Moleculin Biotech (NASDAQ:MBRX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/2021416,500 shares $1.76 million -84.9%1.8%0.2 $4.23
1/29/20212,760,000 shares $15.18 million +8.2%12.6%1.4 $5.50
1/15/20212,550,000 shares $2.47 million +4.9%N/A1 $0.97
12/31/20202,320,000 shares $2.37 million -0.4%N/A1.6 $1.02
12/15/20202,320,000 shares $2.06 million -0.4%N/A1.6 $0.89
11/30/20202,330,000 shares $1.84 million -7.2%N/A1.7 $0.79
11/15/20202,510,000 shares $1.96 million -3.5%N/A5 $0.78
10/30/20202,600,000 shares $2.00 million -11.3%N/A4.9 $0.77
10/15/20202,930,000 shares $2.14 million -5.5%N/A4.1 $0.73
9/30/20203,100,000 shares $2.57 million +2.0%N/A1 $0.83
9/15/20203,040,000 shares $2.43 million -10.3%N/A1 $0.80
8/31/20203,390,000 shares $2.61 million -7.6%N/A1.1 $0.77
8/14/20203,670,000 shares $3.05 million -5.4%N/A1.1 $0.83
7/31/20203,880,000 shares $3.92 million +19.0%N/A1.2 $1.01
7/15/20203,260,000 shares $3.75 million -11.7%N/A1 $1.15
6/30/20203,690,000 shares $4.39 million -13.2%N/A0.7 $1.19
6/15/20204,250,000 shares $4.08 million -3.2%N/A0.8 $0.96
5/29/20204,390,000 shares $4.39 million +8.7%N/A0.7 $1.00
5/15/20204,040,000 shares $4.40 million -28.2%N/A0.7 $1.09
4/30/20205,630,000 shares $6.02 million +10.8%N/A1 $1.07
4/15/20205,080,000 shares $5.44 million +213.6%N/A0.9 $1.07
3/31/20201,620,000 shares $1.85 million +202.9%N/A0.4 $1.14
3/13/2020534,900 shares $604,437.00 -27.4%1.4%1.5 $1.13
2/28/2020736,300 shares $404,965.00 -35.4%1.9%1.1 $0.55
2/14/20201,140,000 shares $649,800.00 -16.8%2.9%1.8 $0.57

Moleculin Biotech (NASDAQ:MBRX) Short Interest FAQ

speech bubbles
speech bubbles











What is Moleculin Biotech's current short interest?

Short interest is the volume of Moleculin Biotech shares that have been sold short but have not yet been covered or closed out. As of February 12th, traders have sold 416,500 shares of MBRX short. 1.76% of Moleculin Biotech's shares are currently sold short. View details.

What is a good short interest percentage for Moleculin Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.76% of Moleculin Biotech's floating shares are currently sold short.

Is Moleculin Biotech's short interest increasing or decreasing?

Moleculin Biotech saw a drop in short interest in February. As of February 12th, there was short interest totaling 416,500 shares, a drop of 84.9% from the previous total of 2,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Moleculin Biotech's float size?

Moleculin Biotech currently has issued a total of 26,279,000 shares. Some of Moleculin Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Moleculin Biotech currently has a public float of 23,600,000 shares.

How does Moleculin Biotech's short interest compare to its competitors?

1.76% of Moleculin Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Moleculin Biotech: Spruce Biosciences, Inc. (5.23%), TherapeuticsMD, Inc. (0.00%), RAPT Therapeutics, Inc. (8.24%), Athersys, Inc. (0.00%), BioDelivery Sciences International, Inc. (0.00%), MEI Pharma, Inc. (0.00%), Verastem, Inc. (0.00%), Kala Pharmaceuticals, Inc. (0.00%), UroGen Pharma Ltd. (14.45%), and Catalyst Pharmaceuticals, Inc. (9.55%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Moleculin Biotech stock?

Short selling MBRX is an investing strategy that aims to generate trading profit from Moleculin Biotech as its price is falling. Moleculin Biotech's stock is trading down $0.05 today. To short Moleculin Biotech stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Moleculin Biotech will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Moleculin Biotech?

A short squeeze for Moleculin Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MBRX, which in turn drives the price of the stock up even further.

How often is Moleculin Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MBRX, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.